August 14, 2016
Quantum Diamond Technologies, Inc. (QDTI), a quantum-powered instrument development company, has received a contract from the National Institute of Standards and Technologies (NIST) to develop a novel analytical and quality control instrument for manufacturing ultra-uniform magnetic nanoparticles and magnetic beads. The recent contract announcement follows on the heels of QDTI’s new results showing that its diamond-based sensor technology can provide high-throughput analysis of single magnetic particles.
This Small Business Innovation Research (SBIR) Phase I contract is the second that QDTI has received. In 2012, the instrument development company was awarded a $1.8 million contract from the Defense Advanced Research Projects Agency to develop a novel quantum technology-powered analysis and magnetic imaging device for the healthcare sector.
“This contract demonstrates the significant industry need for a rapid, analytical, ultra-sensitive detection capability for magnetic nanoparticle and bead manufacture”, said John Pena, Ph.D., Chief Executive Officer of QDTI. “We look forward to working with NIST to develop this exciting new technology and to demonstrate the commercial utility of our quantum technology platform.”
Magnetic nanoparticles and beads are used by a broad range of industries and have critical applications in biomedical research, therapeutics and diagnostics. Although these particles and beads are a $1 billion/year market, innovative and expanded applications for these particles face significant development hurdles due to the lack of a cost-effective commercial technology for effective single-particle quality control.
This NIST SBIR contract shows additional support for QDTI’s quantum technology platform to provide cutting edge magnetic analysis for an application range beyond healthcare. The company’s breakthrough method of rapid, parallelized, high-resolution magnetic field imaging permits a high-throughput, single-particle quality control approach previously unattainable.